 JUPITER, Fla., Jan. 11, 2021 PRNewswire -- Marizyme, Inc. OTCQB: MRZM, a global biotechnology company developing products to reduce the burden of ischemia-reperfusion injury in tissue grafting, organ transplant, and other surgical indications, today announced as of August 2020 the... 